Literature DB >> 2101409

Identification and characterization of a new variant of apolipoprotein E (apo E-Kochi).

T Suehiro1, K Yoshida, T Yamano, F Ohno.   

Abstract

A new variant of apolipoprotein E (apo E), named apo E-Kochi, was identified in the sera of a 29-year-old male with hyperlipoproteinemia as characterized by a broad-beta band. The characteristic double bands of apo E were seen in the isoelectric focusing gel of very low density lipoprotein from the proband and three members of his family. Of the double bands from the probands, the more cationic component was identical to ordinary apo E3 and the other anionic band was located at approximately a distance of one-half charge to the anode side. This anionic band is a new electrophoretical isoform of apo E (apo E-Kochi), and the molecular weight by sodium dodecyl sulfate electrophoresis and its antigenicity against anti apo E serum are the same as apo E3. Sequence analysis of lysyl endopeptidase fragments showed that apo E-Kochi differs from normal apo E3 at residue 145, where an arginine residue is substituted for histidine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2101409     DOI: 10.2169/internalmedicine1962.29.587

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  3 in total

1.  In silico analyses of deleterious missense SNPs of human apolipoprotein E3.

Authors:  Allan S Pires; William F Porto; Octavio L Franco; Sérgio A Alencar
Journal:  Sci Rep       Date:  2017-05-30       Impact factor: 4.379

Review 2.  Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.

Authors:  Britt E Heidemann; Charlotte Koopal; Alexis Baass; Joep C Defesche; Linda Zuurbier; Monique T Mulder; Jeanine E Roeters van Lennep; Niels P Riksen; Christopher Boot; A David Marais; Frank L J Visseren
Journal:  Clin Genet       Date:  2022-08-22       Impact factor: 4.296

Review 3.  Role of apolipoprotein E in neurodegenerative diseases.

Authors:  Vo Van Giau; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2015-07-16       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.